chevron_leftBack
As of 24 April 2025, Morishita Jintan Co., Ltd. has a market cap of $59.89M USD, ranking #23677 globally and #2567 in Japan. It ranks #2392 in the Healthcare sector, and #527 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$59.89MUSD
8.53B JPY
Enterprise Value
$59.5MUSD
8.52B JPY
Revenue (TTM)
$88.7MUSD
12.64B JPY
EBITDA (TTM)
$5.55MUSD
794.75M JPY
Net Income (TTM)
$2.19MUSD
312.0M JPY
EBITDA Margin
6.3%
Profit Margin
2.5%
PE Ratio
27.3
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Yuji Morishita
open_in_new
Employees
354
Founded
1893
Website
jintan.co.jp
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.1% | 1.3% | -7.2% | -0.5% | -0.9% | -10% |
Upcoming Earnings
Earnings Date
Tue, May 13
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4524
森下仁丹株式会社
ISIN: JP3924400009
Shares Out.:
Shares Outstanding:
4.091M1
Shares Float:
1.753M2
|
2.09K JPY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Morishita Jintan Co., Ltd.
Morishita Jintan Co., Ltd. produces and distributes pharmaceuticals, quasi drugs, medical devices, and food products in Japan. It operates through Healthcare Business and Capsule Business divisions. The Healthcare Business division manufactures and sells Jintan branded products, as well as engages in OEM of dietary supplements, cosmetics, foods, etc. The Capsule Business division is involved in the OEM/ODM of pharmaceuticals, foods, etc., as well as the development of industrial use capsules. Morishita Jintan Co., Ltd. was founded in 1893 and is headquartered in Osaka, Japan.
